Goker-Alpan O - Search Results

1

Circulated TGF-β1 and VEGF-A as Biomarkers for Fabry Disease-Associated Cardiomyopathy.

Ivanova MM, Dao J, Slayeh OA, Friedman A, Goker-Alpan O. Ivanova MM, et al. Cells. 2023 Aug 19;12(16):2102. doi: 10.3390/cells12162102. Cells. 2023. PMID: 37626912 Free PMC article.

2

Three classes of glucocerebrosidase inhibitors identified by quantitative high-throughput screening are chaperone leads for Gaucher disease.

Zheng W, Padia J, Urban DJ, Jadhav A, Goker-Alpan O, Simeonov A, Goldin E, Auld D, LaMarca ME, Inglese J, Austin CP, Sidransky E. Zheng W, et al. Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13192-7. doi: 10.1073/pnas.0705637104. Epub 2007 Aug 1. Proc Natl Acad Sci U S A. 2007. PMID: 17670938 Free PMC article.

3

Gaucher disease and the synucleinopathies.

Hruska KS, Goker-Alpan O, Sidransky E. Hruska KS, et al. J Biomed Biotechnol. 2006;2006(3):78549. doi: 10.1155/JBB/2006/78549. J Biomed Biotechnol. 2006. PMID: 17047314 Free PMC article.

4

Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuum.

Eblan MJ, Goker-Alpan O, Sidransky E. Eblan MJ, et al. Fetal Pediatr Pathol. 2005 Jul-Oct;24(4-5):205-22. doi: 10.1080/15227950500405296. Fetal Pediatr Pathol. 2005. PMID: 16396828 Review.

5

Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3.

Goker-Alpan O, Schiffmann R, Park JK, Stubblefield BK, Tayebi N, Sidransky E. Goker-Alpan O, et al. J Pediatr. 2003 Aug;143(2):273-6. doi: 10.1067/S0022-3476(03)00302-0. J Pediatr. 2003. PMID: 12970647

6

Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism.

Eblan MJ, Scholz S, Stubblefield B, Gutti U, Goker-Alpan O, Hruska KS, Singleton AB, Sidransky E. Eblan MJ, et al. Neurosci Lett. 2006 Aug 14;404(1-2):163-5. doi: 10.1016/j.neulet.2006.05.032. Epub 2006 Jun 15. Neurosci Lett. 2006. PMID: 16781064

7

Parkinsonism among Gaucher disease carriers.

Goker-Alpan O, Schiffmann R, LaMarca ME, Nussbaum RL, McInerney-Leo A, Sidransky E. Goker-Alpan O, et al. J Med Genet. 2004 Dec;41(12):937-40. doi: 10.1136/jmg.2004.024455. J Med Genet. 2004. PMID: 15591280 Free PMC article.

8

Divergent phenotypes in Gaucher disease implicate the role of modifiers.

Goker-Alpan O, Hruska KS, Orvisky E, Kishnani PS, Stubblefield BK, Schiffmann R, Sidransky E. Goker-Alpan O, et al. J Med Genet. 2005 Jun;42(6):e37. doi: 10.1136/jmg.2004.028019. J Med Genet. 2005. PMID: 15937077 Free PMC article.

9

Treating patients with Gaucher disease and parkinsonism: misrepresentation in a title.

Goker-Alpan O, Sidransky E. Goker-Alpan O, et al. Parkinsonism Relat Disord. 2008;14(1):81-2; author reply 83. doi: 10.1016/j.parkreldis.2007.01.002. Epub 2007 Mar 9. Parkinsonism Relat Disord. 2008. PMID: 17350320 No abstract available.

10

Hypercholesterolemia in children with Smith-Magenis syndrome: del (17) (p11.2p11.2).

Smith AC, Gropman AL, Bailey-Wilson JE, Goker-Alpan O, Elsea SH, Blancato J, Lupski JR, Potocki L. Smith AC, et al. Genet Med. 2002 May-Jun;4(3):118-25. doi: 10.1097/00125817-200205000-00004. Genet Med. 2002. PMID: 12180145 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters